Research Topics
| L MaherSummaryAffiliation: University of New South Wales Country: Australia Publications
| Collaborators
|
Detail Information
Publications
Blood-borne virus prevalence and risk among steroid injectors: results from the Australian Needle and Syringe Program SurveyCarolyn A Day
Drug Health Services, Central Clinical School, University of Sydney, NSW, Australia
Drug Alcohol Rev 27:559-61. 2008- Risk behaviours of young Indo-Chinese injecting drug users in Sydney and MelbourneL Maher
School of Medical Education, University of New South Wales
Aust N Z J Public Health 25:50-4. 2001..To investigate patterns of drug use and injection-related risk behaviours among young Indo-Chinese injecting drug users (IDUs)... - High hepatitis C incidence in new injecting drug users: a policy failure?Lisa Maher
National Centre in HIV Epidemiology and Clinical Research and School of Public Health and Community Medicine, University of New South Wales, Sydney
Aust N Z J Public Health 31:30-5. 2007..This study aimed to determine incidence of HCV and associated risk factors among new IDUs in Sydney... - 4th International AIDS Society Conference on HIV Pathogenesis, Treatment and PreventionLisa Maher
National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney, NSW, Australia
Med J Aust 187:610-2. 2007 - Incidence and risk factors for hepatitis C seroconversion in injecting drug users in AustraliaLisa Maher
National Centre in HIV Epidemiology and Clinical Research and School of Public Health and Community Medicine, University of New South Wales, Sydney, Australia
Addiction 101:1499-508. 2006..To determine the incidence of hepatitis C virus (HCV) infection and identify risk factors for seroconversion... - Risk behaviors and antibody hepatitis B and C prevalence among injecting drug users in south-western Sydney, AustraliaLisa Maher
School of Public Health and Community Medicine, University of New South Wales, Sydney, NSW, Australia
J Gastroenterol Hepatol 19:1114-20. 2004.... - Overdose beliefs and management practices among ethnic Vietnamese heroin users in Sydney, AustraliaLisa Maher
National Centre in HIV Epidemiology and Clinical Research, Sydney, Australia
Harm Reduct J 6:6. 2009..Implications for overdose prevention, treatment and management are identified and discussed... - Experience of hepatitis C testing among injecting drug users in Sydney, AustraliaC A Day
National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Australia
AIDS Care 20:116-23. 2008..Specialised services for drug users such as methadone clinics and primary healthcare are suitable locations to provide access to testing... - Có vay có tra (What goes around comes around): culture, risk and vulnerability to blood-borne viruses among ethnic Vietnamese injecting drug usersHien Thi Ho
School of Public Health and Community Medicine, University of New South Wales, Sydney, Australia and Hanoi School of Public Health, Vietnam
Drug Alcohol Rev 27:420-8. 2008.... - Estimating population attributable risk for hepatitis C seroconversion in injecting drug users in Australia: implications for prevention policy and planningHandan Wand
National Centre in HIV Epidemiology and Clinical Research, Sydney, Australia
Addiction 104:2049-56. 2009..To determine risk factors and estimate their population-level contribution to hepatitis C virus (HCV) burden... - Representativeness of injecting drug users who participate in HIV surveillance: results from Australia's Needle and Syringe Program SurveyLibby Topp
Viral Hepatitis Epidemiology and Prevention Program, National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Darlinghurst, New South Wales, Australia
J Acquir Immune Defic Syndr 47:632-8. 2008..This study examined the representativeness of NSP Survey samples... - Acceptability of hepatitis C virus testing methods among injecting drug usersBethany White
National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Australia
Drug Alcohol Rev 27:666-70. 2008..The aim of the current study was to determine the acceptability of three methods of hepatitis C virus (HCV) testing among injecting drug users (IDUs): oral fluid, capillary blood and venous blood sampling... - The impact of needle and syringe programs on HIV and HCV transmissions in injecting drug users in Australia: a model-based analysisJisoo A Kwon
National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales, Sydney, New South Wales, Australia
J Acquir Immune Defic Syndr 51:462-9. 2009..We aim to estimate how changes in sterile syringe distribution through needle-syringe programs (NSPs) may affect HIV and hepatitis C virus (HCV) incidence among injecting drug users (IDUs) in Australia... - Self reported risk behaviour among injecting drug users: self versus assisted questionnaire completionB White
Viral Hepatitis Epidemiology and Prevention Program, National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney, NSW, Australia
AIDS Care 19:441-7. 2007..The current findings suggest self-completion of risk behaviour questionnaires should be considered as an alternative to interviewer administered questionnaires to maximise accuracy of self-reports... - Scaling up HIV treatment, care and support for injecting drug users in VietnamLisa Maher
National Centre in HIV Epidemiology and Clinical Research and School of Public Health and Community Medicine, University of New South Wales, Sydney, Australia
Int J Drug Policy 18:296-305. 2007.... - Injecting-related injury and disease among clients of a supervised injecting facilityAllison M Salmon
National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, New South Wales, Australia
Drug Alcohol Depend 101:132-6. 2009..The social and physical environments in which drugs are injected play a significant role in these and other morbidities. Supervised injecting facilities (SIFs) seek to address such issues associated with public injecting drug use... - Clinical trial literacy among injecting drug users in Sydney, Australia: A pilot studyAnna Doab
National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Darlinghurst NSW 2010, Australia
Contemp Clin Trials 30:431-5. 2009.... - Promoting equitable access to hepatitis C treatment for Indo-Chinese injecting drug usersHeidi Coupland
National Centre in HIV Epidemiology and Clinical Research and School of Public Health and Community Medicine, University of New South Wales, Australia
Health Promot J Austr 20:234-40. 2009..Little is known about barriers to treatment uptake among culturally diverse groups of IDUs. Indo-Chinese IDUs represent a marginalised group with high rates of incident and prevalent HCV infection... - Enhancing Aboriginal and Torres Strait Islander young people's resilience to blood-borne and sexually transmitted infections: findings from a community-based participatory research projectJulie Mooney-Somers
National Centre in HIV Epidemiology and Clinical Medicine, University of New South Wales, Sydney, Australia
Health Promot J Austr 20:195-201. 2009.... - Factors influencing a self-limiting HIV outbreak among ethnic Vietnamese injecting drug users in Melbourne, AustraliaPeter Higgs
National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney, New South Wales, Australia
Qual Health Res 19:1690-701. 2009..Early and effective engagement with participants by health care workers also appears to have played an important role in containing the transmission of HIV within this group of ethnic Vietnamese heroin injectors... - Using ethnographic fieldwork to inform hepatitis C vaccine preparedness studies with people who inject drugsLisa Maher
National Centre in HIV Epidemiology and Clinical Research and School of Public Health and Community Medicine, University of New South Wales, Sydney, Australia
Int J Drug Policy 21:194-201. 2010..Feasibility studies are an important component of preparations for field trials of biomedical prevention interventions, including vaccines... - High HIV testing and low HIV prevalence among injecting drug users attending the Sydney Medically Supervised Injecting CentreAllison M Salmon
National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Australia
Aust N Z J Public Health 33:280-3. 2009..Measure the self-reported prevalence of HIV, history of HIV testing and associated risk factors among injecting drug users (IDUs) attending the Sydney Medically Supervised Injecting Centre (MSIC)... - The Indigenous Resiliency Project: a worked example of community-based participatory researchJulie Mooney-Somers
National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Australia
N S W Public Health Bull 20:112-8. 2009..A commentary on the experience of one health worker involved in the project accompanies the paper... - Hepatitis C virus acquisition among injecting drug users: a cohort analysis of a national repeated cross-sectional survey of needle and syringe program attendees in Australia, 1995-2004Kathleen Falster
National Centre in HIV Epidemiology and Clinical Research, School of Public Health and Community Medicine, University of New South Wales, Sydney, Australia
J Urban Health 86:106-18. 2009..In summary, our findings suggest a persistent HCV epidemic despite significant harm reduction efforts in Australia since the mid-1980s, with HIV incidence effectively constant in successive initiation cohorts... - Impact of a reduction in heroin availability on patterns of drug use, risk behaviour and incidence of hepatitis C virus infection in injecting drug users in New South Wales, AustraliaLisa Maher
National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, St Vincent s Medical Centre, 376 Victoria Street, Darlinghurst, Sydney, NSW 10, Australia
Drug Alcohol Depend 89:244-50. 2007.... - The epidemiology of hepatitis C in Australia: notifications, treatment uptake and liver transplantations, 1997-2006Heather F Gidding
National Centre in HIV Epidemiology and Clinical Research, Darlinghurst, NSW 2010, Australia
J Gastroenterol Hepatol 24:1648-54. 2009..The aim of this study was to examine trends in the epidemiology and treatment of HCV in Australia... - Learning from the past: young Indigenous people's accounts of blood-borne viral and sexually transmitted infections as resilience narrativesJulie Mooney-Somers
National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, New South Wales, Australia
Cult Health Sex 13:173-86. 2011.... - A diagnosis of hepatitis C - insights from a study on patients' experiencesCarla Treloar
National Centre in HIV Social Research, The University of New South Wales, Sydney, New South Wales
Aust Fam Physician 39:589-92. 2010..Previous research has documented patient experiences of hepatitis C virus (HCV) diagnosis to be without sufficient pretest and post-test discussions - health professionals have expressed a need for training in this area... - Five years on: what are the community perceptions of drug-related public amenity following the establishment of the Sydney Medically Supervised Injecting Centre?Allison M Salmon
National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, NSW, Australia
Int J Drug Policy 18:46-53. 2007.... - Modelling the hepatitis C virus epidemic in AustraliaKarina Razali
National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney, NSW 2010, Australia
Drug Alcohol Depend 91:228-35. 2007..This paper updates estimates of HCV incidence and prevalence between 1960 and 2005... - Prevalence and predictors of injecting-related injury and disease among clients of Australia's needle and syringe programsLibby Topp
Viral Hepatitis Epidemiology and Prevention Program, National Centre in HIV Epidemiology and Clinical Research, Faculty of Medicine, University of New South Wales, Darlinghurst, New South Wales
Aust N Z J Public Health 32:34-7. 2008..To identify lifetime prevalence and predictors of self-reported injecting-related injuries and diseases (IRID) and/or injecting-related problems (IRP) among a national cross-sectional sample of injecting drug users... - Candidate hepatitis C vaccine trials and people who inject drugs: challenges and opportunitiesLisa Maher
National Centre in HIV Epidemiology and Clinical Research, School of Public Health and Community Medicine, University of New South Wales, Centre for Immunology, Darlinghurst, NSW 2010, Australia
Vaccine 28:7273-8. 2010..Significant biological and social factors and differences between HIV and HCV suggest that HCV warrants targeted vaccine preparedness research to lay the groundwork for successful implementation of future trials... - Is point of access to needles and syringes related to needle sharing? Comparing data collected from pharmacies and needle and syringe programs in south-east SydneyJoanne Bryant
National Centre in HIV Social Research, University of New South Wales, Sydney, NSW 2052, Australia
Drug Alcohol Rev 29:364-70. 2010..This paper examines patterns of equipment acquisition and risk for blood-borne virus transmission among injecting drug users who use pharmacies and needle and syringe programs (NSP) in south-east Sydney... - "Fitness for duty": social, organisational and structural influences on the design and conduct of candidate hepatitis C vaccine trials involving people who inject drugsCarla Treloar
National Centre in HIV Social Research, The University of New South Wales, Sydney, NSW 2052, Australia
Vaccine 28:5228-36. 2010.... - The impact of a supervised injecting facility on ambulance call-outs in Sydney, AustraliaAllison M Salmon
National Centre HIV Epidemiology and Clinical Research, University of New South Wales, Darlinghurst, NSW, Australia
Addiction 105:676-83. 2010.... - Amphetamine-type stimulant use and HIV/STI risk behaviour among young female sex workers in Phnom Penh, CambodiaL Maher
National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney, Australia
Int J Drug Policy 22:203-9. 2011..In Cambodia, recent ATS use is independently associated with incident STI infection among young female sex workers (FSWs)... - Chlamydia in the Pacific region, the silent epidemicSusan J Cliffe
Perinatal and Reproductive Epidemiology and Research Unit, School Women s and Children s Health, University of New South Wales, Randwick, New South Wales, Australia
Sex Transm Dis 35:801-6. 2008.... - Measuring effectiveness of needle and syringe exchange programs for prevention of HIV among injecting drug users: Response to AmundsenLisa Maher
Addiction 101:1834-6. 2006 - Hepatitis C among intravenous drug usersLisa Maher
Epidemiology 16:423; author reply 424. 2005 - How can hepatitis C be prevented in the long term?Pedro Mateu-Gelabert
Center for Drug Use and HIV Research, National Development Research Institutes, New York City, NY, United States
Int J Drug Policy 18:338-40. 2007..These studies aim to provide the conceptual basis for developing a new generation of HCV prevention programs to assist both new and experienced IDUs to remain uninfected over the long run... - Supervised injecting facilities: how much evidence is enough?Lisa Maher
Drug Alcohol Rev 26:351-3. 2007 - Applied communitarian ethics for harm reduction: promoting a dialogue within the fieldCraig Fry
Turning Point Alcohol and Drug Centre Inc and Department of Health Science, Faculty of Medicine, Nursing and Health Sciences, Monash University, Australia
Drug Alcohol Rev 26:553-5. 2007..This 'discursive authenticity' as Hathaway has called it, can help to define a new territory of authority for drug users as participants in harm reduction policy, practice and research... - Methamphetamine: geographic areas and populations at risk, and emerging evidence for effective interventionsLouisa Degenhardt
Drug Alcohol Rev 27:217-9. 2008 - Beyond Olmstead. What the New Freedom Initiative means for long-term careLisa Maher
Contemp Longterm Care 25:19-21. 2002 - Drugs, public health and policing in indigenous communitiesLisa Maher
Drug Alcohol Rev 23:249-51. 2004 - Beneficiaries get green light to appeal Medicare policiesLisa Maher
Contemp Longterm Care 25:8. 2002